Agitation in cognitive disorders:International Psychogeriatric Association provisional consensus clinical and research definition

Article English OPEN
Cummings, Jeffrey ; Mintzer, Jacobo ; Brodaty, Henry ; Sano, Mary ; Banerjee, Sube ; Devanand, D. P. ; Gauthier, Serge ; Howard, Robert ; Lanctôt, Krista ; Lyketsos, Constantine G. ; Peskind, Elaine ; Porsteinsson, Anton P. ; Reich, Edgardo ; Sampaio, Cristina ; Steffens, David ; Wortmann, Marc ; Zhong, Kate (2015)
  • Publisher: Cambridge University Press
  • Journal: volume 27, issue 1, pages 7-17 (issn: 1041-6102, eissn: 1741-203X)
  • Related identifiers: doi: 10.1017/S1041610214001963, pmc: PMC4301197
  • Subject: Food and Drug Administration | Alzheimer's disease | Clinical Psychology | Research Article | aggression | Gerontology | Geriatrics and Gerontology | Psychiatry and Mental health | Alzheimer’s disease | agitation | /dk/atira/pure/subjectarea/asjc/2700/2717 | epidemiology | /dk/atira/pure/subjectarea/asjc/2700/2738 | /dk/atira/pure/subjectarea/asjc/3200/3203 | /dk/atira/pure/subjectarea/asjc/2900/2909 | cognitive impairment | clinical trials | intervention | R1 | International Psychogeriatric Association

Background: Agitation is common across neuropsychiatric disorders and contributes to disability, institutionalization, and diminished quality of life for patients and their caregivers. There is no consensus definition of agitation and no widespread agreement on what ele... View more
  • References (31)
    31 references, page 1 of 4

    American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th edn (DSM-5). Washington, DC: American Psychiatric Association.

    Ballard, C. and Corbett, A. (2010). Management of neuropsychiatric symptoms in people with dementia. CNS Drugs, 24, 729-739. doi:10.2165/11319240.

    Bruen, P. D., McGeown, W. J., Shanks, M. F. and Venneri, A. (2008). Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. Brain, 131, 2455-2463. doi:10.1093/brain/awn151.

    Bruns, M. B. and Josephs, K. A. (2013). Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy. International Review of Psychiatry, 25, 197-209. doi:10.3109/09540261.2013.766154.

    Cohen-Mansfield, J., Marx, M. S. and Rosenthal, A. S. (1989). A description of agitation in a nursing home. Journals of Gerontology, 44, M77-M84.

    Cohen-Mansfield, J. and Mintzer, J. E. (2005). Time for change: the role of nonpharmacological interventions in treating behavior problems in nursing home residents with dementia. Alzheimer Disease & Associated Disorders, 19, 37-40.

    Cummings, J. L. and Jeste, D. V. (2007). Pharmacotherapy of neuropsychiatric syndromes in neurologic disorders: definitional and regulatory aspects. Psychopharmacology Bulletin, 40, 89-98.

    Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A. and Gornbein, J. (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308-2314.

    De Deyn, P. P. and Wirshing, W. C. (2001). Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia. Journal of Clinical Psychiatry, 62 (Suppl. 21), 19-22.

    Draper, B. (1999). The International Psychogeriatric Association - Ninth Congress, 15-20 August 1999, Vancouver, Canada. I Drugs, 2, 1133-1135.

  • Metrics
    0
    views in OpenAIRE
    0
    views in local repository
    69
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    Sussex Research Online - IRUS-UK 0 64
    King's Research Portal - IRUS-UK 0 5
Share - Bookmark